4Lawrence I G, Price, D E, Howlett T A, et al. Correcting importance in the male dialysis patient: experience with testosterone replacement and vacuum tumescence therapy[J]. Am J Kidney Dis, 1998, 31:313 -319.
5NIH Consensus Conference Impotence. NIH Consensus Development Panel on Impotence[ J]. JAMA, 1993, 270:83-90.
6Rosen RC, Riley A, Wagner G, et al. The International Index of Erectile Function (ⅡEF): A multidimensional scale for assessment of erectile dysfunction[J]. Urology. 1997,49:822 - 830.
7Feldman H A , Goldsterin I. Hatzichristou D G, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study[J]. J Urol, 1994, 151:54-61.
8Goldstein I, Lue T F, Padma - Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group[J]. N Engl J Med, 1998, 338:1397 - 1402.
9Boolell M, Allen M J, Ballard S A, et al. Sildenafil: an orally active type 5 cyclic GMP - specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction[J]. Int J Impot Res 1996, 8:47 -52.
10Thurm J. Sexual potency of patients on chronic hemodialysis[ J ]. Urology, 1975,5:60 - 62.
